SCHULER JACK W 4

What Happened

• Jack W. Schuler, a 10% owner of Biodesix, purchased 82,465 shares (Transaction code: P) on January 22, 2026. The filing reports a weighted-average price of $10.96 per share for a total cash outlay of about $903,561. This was a purchase (buy), which insiders’ purchases are often viewed as a more informative/bullish signal than sales.

Key Details

• Transaction date: 2026-01-22; Filing date (Form 4): 2026-01-26.
• Reported price: weighted average $10.96; actual trade prices ranged from $10.675 to $11.10 (footnote F1).
• Total acquired: 82,465 shares; total value ≈ $903,561.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F2 and F3 note Schuler is sole trustee of the Jack W. Schuler Living Trust and the Jack W. Schuler 2025 GRAT, indicating the purchases may have been made in trustee capacity for those trusts.
• Timeliness: The Form 4 was filed four days after the trade; Form 4s are generally required within two business days of the transaction, so this appears later than typical.

Context

• Transaction code P means a direct purchase (open market/private purchase). Footnote F1 states the reported $10.96 is a weighted average and the reporter can provide the breakdown of prices on request.
• As a 10% owner (not necessarily an executive role), Schuler’s trades represent principal/insider ownership activity rather than routine employee option-related transactions. Purchases by significant holders can be of interest to investors, though they do not by themselves indicate motive.